Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 17/20 | 0.68 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | TLR2 | O60603 | 1/20 | 0.55 |
| ▸ | TLR1 | Q15399 | 1/20 | 0.55 |
| ▸ | TLR6 | Q9Y2C9 | 1/20 | 0.55 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | HPGD | P15428 | 1/20 | 0.55 |
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.55 |
| ▸ | ABAT | P80404 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8679776 | 1.00 | ERN1 (0.68) | ERN1LMNAMAPTTLR2TLR1 | |
| SCHEMBL30393705 | 1.00 | ERN1 (0.68) | ERN1LMNAMAPTTLR2TLR1 | |
| SCHEMBL20680483 | 0.89 | ERN1 (0.76) | ERN1TLR2TLR1TLR6 | |
| SCHEMBL8679779 | 0.89 | ERN1 (0.59) | ERN1LMNAMAPTTRIM24ALDH1A1 | |
| Syringaldehyde SCHEMBL2110596 | 0.88 | ALDH1A1 (0.62) | ERN1LMNAMAPTTRIM24ALDH1A1 | |
| Syringaldehyde SCHEMBL150376 | 0.88 | ALDH1A1 (0.62) | ERN1LMNAMAPTTRIM24ALDH1A1 | |
| Syringaldehyde SCHEMBL30119623 | 0.88 | ALDH1A1 (0.62) | ERN1LMNAMAPTTRIM24ALDH1A1 | |
| SCHEMBL22917545 | 0.87 | ERN1 (0.62) | ERN1LMNAMAPTTLR2TLR1 | |
| SCHEMBL4072417 | 0.87 | ERN1 (0.53) | ERN1LMNAMAPTTLR2TLR1 | |
| Syringaldehyde SCHEMBL28642631 | 0.86 | ALDH1A1 (0.60) | ERN1LMNAMAPTTRIM24ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 100 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11484052-B2 | Vanillin and/or ethylvanillin, process for their preparations and use thereof | RHODIA OPERATIONS (FR) | 2022-11-01 | — | — | US | claimed |
| US-20210120854-A1 | NEW VANILLIN AND/OR ETHYLVANILLIN, PROCESS FOR THEIR PREPARATIONS AND USE THEREOF | SPECIALTY OPERATIONS FRANCE (FR) | 2021-04-29 | — | — | US | claimed |
| EP-3658525-A1 | NEW VANILLIN AND/OR ETHYLVANILLIN, PROCESS FOR THEIR PREPARATIONS AND USE THEREOF | Rhodia Operations (FR) | 2020-06-03 | — | — | EP | claimed |
| CN-110944969-A | Novel vanillin and/or ethyl vanillin, method for the production thereof and use thereof | 罗地亚经营管理公司 | 2020-03-31 | — | — | CN | claimed |
| WO-2019020773-A1 | NEW VANILLIN AND/OR ETHYLVANILLIN, PROCESS FOR THEIR PREPARATIONS AND USE THEREOF | RHODIA OPERATIONS (FR) | 2019-01-31 | — | — | WO | claimed |
| US-20190031588-A1 | NEW VANILLIN AND OR ETHYLVANILLIN, PROCESS FOR THEIR PREPARATIONS AND USE THEREOF | SPECIALTY OPERATIONS FRANCE (FR) | 2019-01-31 | — | — | US | claimed |
| US-20170172184-A1 | Methods of Improving Production of Vanillin | EVOLVA SA (CH) | 2017-06-22 | — | — | US | claimed |
| WO-2015121379-A2 | METHODS OF IMPROVING PRODUCTION OF VANILLIN | EVOLVA SA (CH) | 2015-08-20 | — | — | WO | claimed |
| EP-0946482-B1 | METHOD FOR PREPARING A 4-HYDROXYBENZALDEHYDE AND DERIVATIVES | RHODIA CHIMIE SA (FR) | 2002-07-24 | — | — | EP | claimed |
| US-6184421-B1 | SELECTIVE OXIDATION, TO A CARBOXY GROUP, OF THE GROUP IN THE 2 POSITION WITH RESPECT TO THE HYDROXYL GROUPS OF A MIXTURE OF PHENOLS HAVING FORMYL AND/OR HYDROXYMETHYL GROUPS IN POSITIONS 2 OR 4; PREPARING VANILLIN AND ETHYL VANILLIN | RHODIA CHIMIE (FR) | 2001-02-06 | — | — | US | claimed |
| EP-0773919-B1 | METHOD FOR PREPARING 3-CARBOXY-4-HYDROXYBENZALDEHYDES AND DERIVATIVES THEREOF | RHODIA CHIMIE SA (FR) | 2000-09-20 | — | — | EP | claimed |
| EP-0946482-A1 | METHOD FOR PREPARING A 4-HYDROXYBENZALDEHYDE AND DERIVATIVES | RHODIA CHIMIE (FR) | 1999-10-06 | — | — | EP | claimed |
| US-5783737-A | Process for the preparation of 3-carboxy-4-hydroxybenzaldehides and derivatives thereof | RHONE-POULENC CHIMIE (FR) | 1998-07-21 | — | — | US | claimed |
| WO-1998022419-A1 | METHOD FOR PREPARING A 4-HYDROXYBENZALDEHYDE AND DERIVATIVES | RHODIA CHIMIE (FR) | 1998-05-28 | — | — | WO | claimed |
| EP-0773919-A1 | METHOD FOR PREPARING 3-CARBOXY-4-HYDROXYBENZALDEHYDES AND DERIVATIVES THEREOF | RHONE-POULENC CHIMIE (FR) | 1997-05-21 | — | — | EP | claimed |
| WO-1996037454-A1 | METHOD FOR PREPARING 3-CARBOXY-4-HYDROXYBENZALDEHYDES AND DERIVATIVES THEREOF | RHONE-POULENC CHIMIE (FR) | 1996-11-28 | — | — | WO | claimed |
| US-4474994-A | EXTRACTION WITH CARBON DIOXIDE | MONSANTO COMPANY (US) | 1984-10-02 | — | — | US | claimed |
| EP-0044260-B1 | PROCESS FOR THE PREPARATION OF POLYPHENOLS OPTIONALLY SUBSTITUTED BY AN ALDEHYDE GROUP | RHONE-POULENC SPECIALITES CHIMIQUES (FR) | 1984-04-11 | — | — | EP | claimed |
| US-4435601-A | OXIDATION WITH HYDROGEN PEROXIDE IN ALKALI OR ALKALINE METAL BASE | RHONE-POULENC INDUSTRIES (FR) | 1984-03-06 | — | — | US | claimed |
| EP-4423163-B1 | BIOBASED AMINE CURING AGENT FOR CURABLE COMPOSITIONS | SIKA TECH AG (CH) | 2025-06-25 | — | — | EP | disclosed |
| US-20240360271-A1 | BIO-BASED AMINE CURING AGENT FOR CURABLE COMPOSITIONS | SIKA TECHNOLOGY AG (CH) | 2024-10-31 | — | — | US | disclosed |
| EP-4423163-A1 | BIO-BASED AMINE CURING AGENT FOR CURABLE COMPOSITIONS | Sika Technology AG (CH) | 2024-09-04 | — | — | EP | disclosed |
| CN-118019775-A | Bio-based amine curing agents for curable compositions | SIKA技术股份公司 | 2024-05-10 | — | — | CN | disclosed |
| US-11826396-B2 | Nutriprotective diet | FEDERATION DES PRODUCTEURS ACERICOLES DU QUEBEC (CA) | 2023-11-28 | — | — | US | disclosed |
| WO-2023072786-A1 | BIO-BASED AMINE CURING AGENT FOR CURABLE COMPOSITIONS | SIKA TECHNOLOGY AG (CH) | 2023-05-04 | — | — | WO | disclosed |
| US-11484052-B2 | Vanillin and/or ethylvanillin, process for their preparations and use thereof | RHODIA OPERATIONS (FR) | 2022-11-01 | — | — | US | disclosed |
| US-20210120854-A1 | NEW VANILLIN AND/OR ETHYLVANILLIN, PROCESS FOR THEIR PREPARATIONS AND USE THEREOF | SPECIALTY OPERATIONS FRANCE (FR) | 2021-04-29 | — | — | US | disclosed |
| US-20210120854-A1 | NEW VANILLIN AND/OR ETHYLVANILLIN, PROCESS FOR THEIR PREPARATIONS AND USE THEREOF | SPECIALTY OPERATIONS FRANCE (FR) | 2021-04-29 | — | — | US | disclosed |
| EP-3658525-A1 | NEW VANILLIN AND/OR ETHYLVANILLIN, PROCESS FOR THEIR PREPARATIONS AND USE THEREOF | Rhodia Operations (FR) | 2020-06-03 | — | — | EP | disclosed |
| CN-110944969-A | Novel vanillin and/or ethyl vanillin, method for the production thereof and use thereof | 罗地亚经营管理公司 | 2020-03-31 | — | — | CN | disclosed |
| US-20190070245-A1 | NUTRIPROTECTIVE DIET | FÉDÉRATION DES PRODUCTEURS ACÉRICOLES DU QUÉBEC (CA) | 2019-03-07 | — | — | US | disclosed |
| WO-2019020773-A1 | NEW VANILLIN AND/OR ETHYLVANILLIN, PROCESS FOR THEIR PREPARATIONS AND USE THEREOF | RHODIA OPERATIONS (FR) | 2019-01-31 | — | — | WO | disclosed |
| WO-2019020773-A1 | NEW VANILLIN AND/OR ETHYLVANILLIN, PROCESS FOR THEIR PREPARATIONS AND USE THEREOF | RHODIA OPERATIONS (FR) | 2019-01-31 | — | — | WO | disclosed |
| US-20190031588-A1 | NEW VANILLIN AND OR ETHYLVANILLIN, PROCESS FOR THEIR PREPARATIONS AND USE THEREOF | SPECIALTY OPERATIONS FRANCE (FR) | 2019-01-31 | — | — | US | disclosed |
| US-20190031588-A1 | NEW VANILLIN AND OR ETHYLVANILLIN, PROCESS FOR THEIR PREPARATIONS AND USE THEREOF | SPECIALTY OPERATIONS FRANCE (FR) | 2019-01-31 | — | — | US | disclosed |
| US-9981901-B2 | IRE-1α inhibitors | FOSUN ORINOVE PHARMATECH, INC. (CN) | 2018-05-29 | — | — | US | disclosed |
| EP-2754712-B1 | MUTANT ENDOGLUCANASE | TORAY INDUSTRIES (JP) | 2017-10-04 | — | — | EP | disclosed |
| US-20170172184-A1 | Methods of Improving Production of Vanillin | EVOLVA SA (CH) | 2017-06-22 | — | — | US | disclosed |
| US-20170152206-A1 | IRE-1alpha INHIBITORS | FOSUN ORINOVE PHARMATECH, INC. (CN) | 2017-06-01 | — | — | US | disclosed |
| EP-3150589-A1 | IRE-1A INHIBITORS | MannKind Corporation (US) | 2017-04-05 | — | — | EP | disclosed |
| US-9546149-B2 | IRE-1α inhibitors | MANNKIND CORPORATION (US) | 2017-01-17 | — | — | US | disclosed |
| US-20160229840-A1 | ACTIVATABLE FLUOROGENIC COMPOUNDS AND USES THEREOF AS NEAR INFRARED PROBES | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2016-08-11 | — | — | US | disclosed |
| CN-103450077-B | IRE-1 alpha inhibitor | 满康德股份有限公司 | 2016-07-06 | — | — | CN | disclosed |
| US-20160168116-A1 | IRE-1alpha Inhibitors | FOSUN ORINOVE PHARMATECH, INC. (CN) | 2016-06-16 | — | — | US | disclosed |
| US-9341630-B2 | Activatable fluorogenic compounds and uses thereof as near infrared probes | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2016-05-17 | — | — | US | disclosed |
| US-9241942-B2 | IRE-1α inhibitors | MANNKIND CORPORATION (US) | 2016-01-26 | — | — | US | disclosed |
| CN-105203514-A | Reagent and method for fluorescence detection of hypochlorous acid (HClO) | UNIV SHANXI | 2015-12-30 | — | — | CN | disclosed |
| US-9193963-B2 | Mutant endoglucanase | TORAY INDUSTRIES, INC. (JP) | 2015-11-24 | — | — | US | disclosed |
| WO-2015121379-A2 | METHODS OF IMPROVING PRODUCTION OF VANILLIN | EVOLVA SA (CH) | 2015-08-20 | — | — | WO | disclosed |
| US-20140178947-A1 | MUTANT ENDOGLUCANASE | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2014-06-26 | — | — | US | disclosed |
| US-20140080832-A1 | IRE-1alpha INHIBITORS | MANNKIND CORPORATION (US) | 2014-03-20 | — | — | US | disclosed |
| US-8614253-B2 | IRE-1α inhibitors | MANNKIND CORPORATION (US) | 2013-12-24 | — | — | US | disclosed |
| EP-2591023-A2 | DEGRADABLE SUPERABSORBENT POLYMERS | Reluceo Inc. (US) | 2013-05-15 | — | — | EP | disclosed |
| US-20130065765-A1 | DEGRADABLE SUPERABSORBENT POLYMERS | RELUCEO, INC. | 2013-03-14 | — | — | US | disclosed |
| EP-2532643-A1 | IRE-1A Inhibitors | MannKind Corporation (US) | 2012-12-12 | — | — | EP | disclosed |
| EP-2520561-A1 | IRE-1A Inhibitors | MannKind Corporation (US) | 2012-11-07 | — | — | EP | disclosed |
| WO-2012006278-A2 | DEGRADABLE SUPERABSORBENT POLYMERS | RELUCEO, INC. (US) | 2012-01-12 | — | — | WO | disclosed |
| CN-102015606-A | IRE-1 alpha inhibitors | MANNKIND CORP | 2011-04-13 | — | — | CN | disclosed |
| US-7858666-B2 | inositol requiring enzyme 1 (IRE-1 alpha) inhibitors such as 2-hydroxy-6-(5-(4-methylpiperazine-1-carbonyl)thiophen-2-yl)-1-naphthaldehyde, relieve protein folding stress by enhancing molecular chaperone activity and protects cells from stress induced apoptosis; autoimmune diseases; anticancer; viricides | MANNKIND CORPORATION (US) | 2010-12-28 | — | — | US | disclosed |
| EP-2155643-A1 | IRE-1A INHIBITORS | MannKind Corporation (US) | 2010-02-24 | — | — | EP | disclosed |
| US-20090186893-A1 | IRE-1alpha INHIBITORS | MANNKIND CORPORATION (US) | 2009-07-23 | — | — | US | disclosed |
| WO-2008154484-A1 | IRE-1A INHIBITORS | MANNKIND CORPORATION (US) | 2008-12-18 | — | — | WO | disclosed |
| US-6461423-B1 | PHYLLOSILICATES | AMCOL INTERNATIONAL CORPORATION | 2002-10-08 | — | — | US | disclosed |
| EP-0946482-B1 | METHOD FOR PREPARING A 4-HYDROXYBENZALDEHYDE AND DERIVATIVES | RHODIA CHIMIE SA (FR) | 2002-07-24 | — | — | EP | disclosed |
| EP-0780340-B1 | Intercalates and exfoliates formed with functional monomeric organic compounds; composite materials containing same and methods of modifying rheology therewith | AMCOL INTERNATIONAL CORP (US) | 2002-03-20 | — | — | EP | disclosed |
| US-6184421-B1 | SELECTIVE OXIDATION, TO A CARBOXY GROUP, OF THE GROUP IN THE 2 POSITION WITH RESPECT TO THE HYDROXYL GROUPS OF A MIXTURE OF PHENOLS HAVING FORMYL AND/OR HYDROXYMETHYL GROUPS IN POSITIONS 2 OR 4; PREPARING VANILLIN AND ETHYL VANILLIN | RHODIA CHIMIE (FR) | 2001-02-06 | — | — | US | disclosed |
| US-6126734-A | FORMED BY CONTACTING A LAYERED MATERIAL SUCH AS SODIUM BENTONITE HAVING GIVEN WATER CONTENT, WITH AN INTERCALANT ORGANIC MONOMER COMPRISING C6-24 ALCOHOLS, OR POLYHYDRIC ALCOHOLS; USE AS PLASTICIZERS, THICKENERS | AMCOL INTERNATIONAL CORPORATION (US) | 2000-10-03 | — | — | US | disclosed |
| EP-0773919-B1 | METHOD FOR PREPARING 3-CARBOXY-4-HYDROXYBENZALDEHYDES AND DERIVATIVES THEREOF | RHODIA CHIMIE SA (FR) | 2000-09-20 | — | — | EP | disclosed |
| US-6083559-A | CONTACTING PHYLLOSILICATES WITH INTERCALANT AND CARRIER | AMCOL INTERNATIONAL CORPORATION (US) | 2000-07-04 | — | — | US | disclosed |
| EP-0946482-A1 | METHOD FOR PREPARING A 4-HYDROXYBENZALDEHYDE AND DERIVATIVES | RHODIA CHIMIE (FR) | 1999-10-06 | — | — | EP | disclosed |
| US-5830528-A | MULTILAYER; CONTAINING PHYLLOSILICATE | AMCOL INTERNATIONAL CORPORATION (US) | 1998-11-03 | — | — | US | disclosed |
| US-5783737-A | Process for the preparation of 3-carboxy-4-hydroxybenzaldehides and derivatives thereof | RHONE-POULENC CHIMIE (FR) | 1998-07-21 | — | — | US | disclosed |
| WO-1998022419-A1 | METHOD FOR PREPARING A 4-HYDROXYBENZALDEHYDE AND DERIVATIVES | RHODIA CHIMIE (FR) | 1998-05-28 | — | — | WO | disclosed |
| US-5705703-A | ENZYME INHIBITORS OF TRANSFERASES | HOFFMANN-LA ROCHE INC. (US) | 1998-01-06 | — | — | US | disclosed |
| EP-0780340-A1 | Intercalates and exfoliates formed with functional monomeric organic compounds; composite materials containing same and methods of modifying rheology therewith | AMCOL INTERNATIONAL CORPORATION (US) | 1997-06-25 | — | — | EP | disclosed |
| US-5633371-A | ENZYME INHIBITORS; TREATMENT OF DEPRESSION AND PARKINSON*S DISEASE | HOFFMANN-LA ROCHE INC. (US) | 1997-05-27 | — | — | US | disclosed |
| EP-0773919-A1 | METHOD FOR PREPARING 3-CARBOXY-4-HYDROXYBENZALDEHYDES AND DERIVATIVES THEREOF | RHONE-POULENC CHIMIE (FR) | 1997-05-21 | — | — | EP | disclosed |
| WO-1996037454-A1 | METHOD FOR PREPARING 3-CARBOXY-4-HYDROXYBENZALDEHYDES AND DERIVATIVES THEREOF | RHONE-POULENC CHIMIE (FR) | 1996-11-28 | — | — | WO | disclosed |
| US-5476875-A | Catechol derivatives | HOFFMAN-LA ROCHE INC. (US) | 1995-12-19 | — | — | US | disclosed |
| US-5389653-A | Inhibitors of the enzyme catechol-O-methyltransferase; useful as co-medication in treatment of Parkinson's disease | HOFFMAN-LA ROCHE INC. (US) | 1995-02-14 | — | — | US | disclosed |
| US-5283352-A | Transferase inhibitor | ORION-YHTYMA OY (FI) | 1994-02-01 | — | — | US | disclosed |
| US-5236952-A | Inhibit the enzyme catechol-O-methyltransferase; for treatment of Parkinson's disease administered with L-dopa | HOFFMANN-LA ROCHE INC. (US) | 1993-08-17 | — | — | US | disclosed |
| EP-0237929-B1 | 3,5-DISUBSTITUTED PYROCATECHOL DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 1993-06-02 | — | — | EP | disclosed |
| US-5112861-A | Inhibitors of catechol-methyl-transferase enzyme, levodopa | ORION-YHTYMA OY (FI) | 1992-05-12 | — | — | US | disclosed |
| US-4963590-A | ENZYME INHIBITOR FOR TREATING PARKINSON'S DISEASE ALONG WITH DOPA;POTENTIATION | ORION-YHTYMA OY (FI) | 1990-10-16 | — | — | US | disclosed |
| US-4847422-A | BY-PRODUCTS OF WOOD PULP LIQUOR, OXIDATION, PURIFICATION | YHTYNEET PAPERITEHTAAT OY (FI) | 1989-07-11 | — | — | US | disclosed |
| EP-0299620-A1 | Thiazolidinedione derivatives | BEECHAM GROUP PLC (GB) | 1989-01-18 | — | — | EP | disclosed |
| EP-0237929-A1 | 3,5-Disubstituted pyrocatechol derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 1987-09-23 | — | — | EP | disclosed |
| EP-0091011-B1 | PROCESS FOR THE PREPARATION OF PHENYL ETHERS | ITT INDUSTRIES, INC. (US) | 1987-08-05 | — | — | EP | disclosed |
| EP-0100451-B1 | PROCESS FOR THE HYDROXYLATION OF AROMATIC COMPOUNDS | ITT INDUSTRIES, INC. (US) | 1986-11-05 | — | — | EP | disclosed |
| US-4551305-A | SULFITE LIQUOR, SUGAR, BASE, ALDEHYDE, ACETIC ACID | INTERNATIONAL TELEPHONE AND TELEGRAPH CORPORATION (US) | 1985-11-05 | — | — | US | disclosed |
| US-4474994-A | EXTRACTION WITH CARBON DIOXIDE | MONSANTO COMPANY (US) | 1984-10-02 | — | — | US | disclosed |
| US-4465864-A | Process of hydroxylation of an aromatic carbonyl compound | INTERNATIONAL TELEPHONE AND TELEGRAPH CORPORATION (US) | 1984-08-14 | — | — | US | disclosed |
| US-4453004-A | Process for the alkylation of phenolic compounds | INTERNATIONAL TELEPHONE AND TELEGRAPH CORPORATION (US) | 1984-06-05 | — | — | US | disclosed |
| US-4453017-A | ETHERS FROM PHENOLIC ALDEHYDES, ACIDS, OR AMIDES | INTERNATIONAL TELEPHONE AND TELEGRAPH CORPORATION (US) | 1984-06-05 | — | — | US | disclosed |
| US-4453018-A | ONE-STEP PREPARATION OF ALKYLATED PHENOLIC ETHERS | INTERNATIONAL TELEPHONE AND TELEGRAPH CORPORATION (US) | 1984-06-05 | — | — | US | disclosed |
| US-4435601-A | OXIDATION WITH HYDROGEN PEROXIDE IN ALKALI OR ALKALINE METAL BASE | RHONE-POULENC INDUSTRIES (FR) | 1984-03-06 | — | — | US | disclosed |
| EP-0100451-A1 | Process for the hydroxylation of aromatic compounds | ITT INDUSTRIES, INC. (US) | 1984-02-15 | — | — | EP | disclosed |
| EP-0091011-A2 | Process for the preparation of phenyl ethers | ITT INDUSTRIES, INC. (US) | 1983-10-12 | — | — | EP | disclosed |
| US-4165341-A | FROM CATECHOL OR A 2-ALKOXYPHENOL AND GLYCOLIC ACID USING ALUMINA OR SILICA CATALYST, OXIDATION | UBE INDUSTRIES, LTD. (JP) | 1979-08-21 | — | — | US | disclosed |
| US-4165341-A | FROM CATECHOL OR A 2-ALKOXYPHENOL AND GLYCOLIC ACID USING ALUMINA OR SILICA CATALYST, OXIDATION | UBE INDUSTRIES, LTD. (JP) | 1979-08-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11826396-B2 | Nutriprotective diet | NEFM, NNMT, SORD | ERN1 4711/4885LMNA 2732/4885MAPT 126/4885 |
| US-20210120854-A1 | NEW VANILLIN AND/OR ETHYLVANILLIN, PROCESS FOR THEIR PREPARATIONS AND USE THEREOF | COMT, VARS1, BPGM | ERN1 1351/4885LMNA 2337/4885MAPT 2368/4885 |
| US-20170152206-A1 | IRE-1alpha INHIBITORS | XBP1, DDIT3, ERN1 | ERN1 3/4885LMNA 1886/4885MAPT 3095/4885 |
| US-20160229840-A1 | ACTIVATABLE FLUOROGENIC COMPOUNDS AND USES THEREOF AS NEAR INFRARED PROBES | PAICS, NQO1, APEX1 | ERN1 2602/4885LMNA 931/4885MAPT 3924/4885 |
| US-20160168116-A1 | IRE-1alpha Inhibitors | XBP1, DDIT3, ERN1 | ERN1 3/4885LMNA 1886/4885MAPT 3095/4885 |
| US-20140080832-A1 | IRE-1alpha INHIBITORS | XBP1, DDIT3, ERN1 | ERN1 3/4885LMNA 1886/4885MAPT 3095/4885 |
| US-20190070245-A1 | NUTRIPROTECTIVE DIET | NEFM, NNMT, SORD | ERN1 4711/4885LMNA 2732/4885MAPT 126/4885 |
| US-20090186893-A1 | IRE-1alpha INHIBITORS | XBP1, DDIT3, ERN1 | ERN1 3/4885LMNA 1886/4885MAPT 3095/4885 |
| US-11484052-B2 | Vanillin and/or ethylvanillin, process for their preparations and use thereof | COMT, VARS1, BPGM | ERN1 1109/4885LMNA 2417/4885MAPT 2360/4885 |
| US-20190031588-A1 | NEW VANILLIN AND OR ETHYLVANILLIN, PROCESS FOR THEIR PREPARATIONS AND USE THEREOF | VARS1, COMT, BPGM | ERN1 1093/4885LMNA 2530/4885MAPT 2613/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.